Morning Overview on MSN
Eli Lilly’s new Zepbound pen packs a full month of obesity doses
Eli Lilly and Company (NYSE: LLY) announced on February 23, 2026, that the U.S. Food and Drug Administration has approved a ...
The FDA-approved Zepbound KwikPen delivers a full month of treatment in one device and will be available to self-pay patients through LillyDirect starting Feb. 23.
Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances. We do not ...
Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances. We do not ...
Season 1's a hit, I'd say.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results